dr. tauer on arguments in favor of and against biosimilars in oncology
Published 4 years ago • 275 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
1:48
dr. markman on the concept of biosimilars in oncology
-
1:17
dr. tauer on the potential impact of biosimilars on cancer research funding
-
0:49
dr. robson discusses differences between biosimilars and biologics in oncology
-
5:56
the complexity of choosing biosimilars in oncology
-
0:41
similarity of biosimilars and biologics
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
38:15
biosimilars and biologics
-
0:42
dr. cristofanilli on the need for biosimilars in oncology
-
6:35
how biosimilar medicines will replace generic medicines in the future!!!
-
8:07
biosimilars | what is a biosimilar? | gastrointestinal society
-
25:57
biologics and biosimilars: information for healthcare providers
-
1:00
dr. kris on the impact of bevacizumab biosimilars in lung cancer
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
1:44
dr. schmid on challenges concerning biosimilars in oncology
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
0:53
dr. puhalla on the value of biosimilars in oncology
-
1:42
dr. verma discusses challenges with biosimilars in oncology
-
0:52
dr. offin on potential implications of introducing biosimilars into oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
0:53
dr. schmid on evaluating biosimilars in oncology
-
6:01
economic impact of biosimilars in oncology
-
0:44
dr. hamilton on the impact of biosimilars in oncology